Clinical Trials Logo

Filter by:
NCT ID: NCT02854748 Not yet recruiting - Clinical trials for Diabetes Mellitus, Type II

Evaluate the Drug-drugs Interaction Between Lobeglitazone and Empagliflozin

Start date: August 2016
Phase: Phase 1
Study type: Interventional

This study is a randomized, open-label, multiple dosing, crossover study to evaluate the drug-drugs interaction between Lobeglitazone and Empagliflozin in healthy male volunteers

NCT ID: NCT02854891 Not yet recruiting - Myopia Clinical Trials

Ambient Light Levels in the Kindergarten and Schools and the Relation to Refractive Development

Start date: August 2016
Phase: N/A
Study type: Observational

Myopia, the most common human eye disorder, is a phenomenon characterized by an unconstrained elongation of the eye globe There are number of theories concerning the environmental effect on the emmetropization process, most are related to childhood exposure to outdoor activity, near work and sleep with night light. Studies in lab animals found an association between intensity of ambient lighting and myopia development. In this study, the investigators will examine the ambient light in kindergarten and schools and their relation to refractive error. Diurnal luminance in kindergarten and school class room will be measured and correlated to biometric measures such as refraction, axial length and keratometry.

NCT ID: NCT02855424 Not yet recruiting - Stroke Clinical Trials

The Effect of Leg Cycling Exercise Program at Low or Moderate Intensity for Individuals With Subacute Stroke

Start date: August 2016
Phase: N/A
Study type: Interventional

Poor cardiopulmonary endurance is observed in individuals with acute stroke, even in chronic. In addition, the poor fitness may obstacle activities of daily life, decrease activities of autonomic system, and increase risks of recurrent, therefore, the cardiopulmonary endurance training should be included into the early-stage rehabilitation program. The ergocycling training could improve cardiopulmonary endurance for individuals with stroke. Moreover, the low-intensity exercise training can increase the willingness, and it is safer than the moderate-intensity exercise training. However, it needs to be evaluated whether the low-intensity exercise training can bring sufficient benefits, compared to the moderate-intensity exercise training. Objectives of the study is to compare the exercise benefits between the low-intensity and moderate-intensity exercise training, and then these would offer optimal exercise prescription and considerations in clinical practice.

NCT ID: NCT02856386 Not yet recruiting - Clinical trials for Antibiotic-associated Diarrhea

Use of a Dietary Supplement to Support Digestive Health in Children With Chronic Diarrhea

Start date: August 2016
Phase: N/A
Study type: Interventional

Micronutrients missing in the diet may assist in supporting digestive health in children with chronic GI issues. This study will monitor changes in symptoms associated with digestive problems in children provided with a dietary supplement that will be taken in conjunction with the standard of care.

NCT ID: NCT02857530 Not yet recruiting - Anemia, Aplastic Clinical Trials

Efficacy and Safety of Thrombopoietin In Patients With Severe and Very Severe Aplastic Anemia

Start date: August 2016
Phase: Phase 2
Study type: Interventional

Efficacy and Safety of Recombinant human thrombopoietin in patients with severe aplastic anemia and very severe aplastic anemia, a randomized, double-blind, placebo-controlled, II phase, multi-center clinical research.

NCT ID: NCT02858232 Not yet recruiting - Solid Tumors Clinical Trials

MASCT-I Treatment for Advanced Solid Tumor

Start date: August 2016
Phase: Phase 1/Phase 2
Study type: Interventional

Multiple Target Antigen Stimulating Cell Therapy (MASCT-I) is a new immunotherapy that dendritic cells(DC) was induced from autologous peripheral blood. The DC can then be loaded with antigens and re-infused. In vitro, antigen-pulsed DC can stimulate autologous T-cell proliferation and induction of autologous specific cytotoxic T-cells(CTL),similarly re-infused. The previous research data showed that MASCT had the modest overall response and less adverse effects for Hepatocellular Carcinoma patients. The study is aimed to evaluate the safety of MASCT-1 in patients with advanced solid tumors.

NCT ID: NCT02859077 Not yet recruiting - Clinical trials for Non-Small-Cell Lung Cancer

EGFR-TKI With Chemotherapy in NSCLC Patients With Both EGFR Mutation and BIM Deletion Polymorphism

Start date: August 2016
Phase: Phase 3
Study type: Interventional

BIM deletion polymorphism might be associated with a poor clinical response to EGFR-TKIs in patients who had NSCLC with EGFR mutations. In the study, the investigators want to use EGFR-TKI with chemotherapy as first line treatment in stage IIIB/IV NSCLC patients with both EGFR mutation and BIM deletion polymorphism.

NCT ID: NCT02861677 Not yet recruiting - Clinical trials for Health Care Improvement

Impact of Clinical Pharmacy Service on Patient Care and Cost Saving

TGPIONEER
Start date: August 2016
Phase: N/A
Study type: Interventional

Background: Pharmacists have been proven to improve patient outcomes, medication adherence, glycemic control, reduce blood pressure, low-density lipoprotein, health care costs and length of hospital stay, and enhance quality of life. Objective: to measure the impact of clinical pharmacy service on patient care and cost saving of patients at inpatient wards and ambulatory care clinics of Jimma University Specialized Hospital. Methods: single center Randomized Controlled Trial will be conducted. Participants will be assigned to either pharmacy professionals' intervention group or non-intervention (control) group based on computer generated random number. The study will be done from July 26 to September 15, 2016. The total sample size is calculated with Open Epi online sample size calculator with 95% CI and 80% power. The total sample size is found to be 146 for inpatients and 473 for outpatients. Linear regression, student's t-test, logistic regression and chi-square test will be used for statistical analysis. Variables with p<0.05 will be considered statistically significant.

NCT ID: NCT02862444 Not yet recruiting - Clinical trials for Postpartum Depression

A Culturally Appropriate Intervention for Preventing and Reducing Postpartum Depression

Start date: August 2016
Phase: N/A
Study type: Observational

Postpartum depression (PPD) is a highly prevalent and serious mental health problem and is defined as the most recent episode of depression occurring between four weeks and twelve months after childbirth. PPD has negative effects, which are usually strongest during the first six months and may decrease the quality of mother-child interaction, adversely affecting the child's behavior and emotional and cognitive development, as well as the spouse marital relationship.PPD prevalence is estimated at 10 to 20%. A recent studies among Arab-Bedouin women, reported 31% - 43 of PPD. Aims: To develop and implement a culturally appropriate intervention program by using focus group (FGs) methodology Methods and Research program description: The study includes two phases. First, qualitative study will be conducted by using focus groups (FGs) method and based on the results of this phase we will develop a culturally based program. The second phase will include implementation and evaluation of the effectiveness of a culturally appropriate intervention.

NCT ID: NCT02863367 Not yet recruiting - Clinical trials for Metastatic Pancreatic Cancer

A One-Arm Exploratory Clinical Trial of Apatinib Plus Gemcitabine in Patients With Advanced Metastatic Pancreatic Cancer

OECTAPGAMPC
Start date: August 2016
Phase: Phase 2
Study type: Interventional

Evaluate the efficacy and safety of Apatinib (500mg/d) with gemcitabine(1000mg/m2) in advanced metastatic pancreatic cancer.